Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations

Blood

Volumn 114, Issue 3, 2009, Pages 686-692

  Bos, Mettine H A ^a   Boltz, Michael ^a   St Pierre, Liam ^b   Masci, Paul P ^c   De Jersey, John ^c   Lavin, Martin F ^b,d   Camire, Rodney M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; APC; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; PROCOAGULANT; SNAKE VENOM; THROMBOPLASTIN;

ARTICLE; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SNAKE; ANIMAL; BLOOD CLOTTING; CHEMISTRY; ENZYMOLOGY; PHYSIOLOGY; PROTEIN STABILITY; SEQUENCE ALIGNMENT;

ANIMALS; BLOOD COAGULATION; FACTOR V; FACTOR XA; HEMOSTASIS; HUMANS; PROTEIN STABILITY; SEQUENCE ALIGNMENT; SNAKE VENOMS; SNAKES; THROMBOPLASTIN;

EID: 70149107327     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-202663     Document Type: Article

References (36)

1. Mann KG, Nesheim ME, Church WR, Haley PE, Krishnaswamy S. Surface dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990;76:1-16. (Pubitemid 20220784)
2. Markland FS. Snake venoms and the hemostatic system. Toxicon. 1998;36:1749-1800.
3. Sutherland S, Tibballs J. Australian Animal Toxins: The Creatures, Their Toxins and Care of the Poisoned Patient. Melbourne, Australia: Oxford University Press; 2001.
4. Walker FJ, Owen WG, Esmon CT. Characterization of the prothrombin activator from the venom of Oxyuranus scutellatus scutellatus (taipan venom). Biochemistry. 1980;19:1020-1023.
5. Masci PP, Whitaker AN, de Jersey J. Purification and characterization of a prothrombin activator from the venom of the Australian brown snake, Pseudonaja textilis textilis. Biochem Int. 1988;17:825-835.
6. Speijer H, Govers-Riemslag JW, Zwaal RF, Rosing J. Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake). J Biol Chem. 1986;261:13258-13267. (Pubitemid 17006905)
7. Rao VS, Kini RM. Pseutarin C, a prothrombin activator from Pseudonaja textilis venom: its structural and functional similarity to mammalian coagulation factor Xa-Va complex. Thromb Haemost. 2002;88:611-619.
8. Rao VS, Swarup S, Kini RM. The nonenzymatic subunit of pseutarin C, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom, shows structural similarity to mammalian coagulation factor V. Blood. 2003;102:1347-1354. (Pubitemid 36988042)
9. Rao VS, Swarup S, Kini RM. The catalytic subunit of pseutarin C, a group C prothrombin activator from the venom of Pseudonaja textilis, is structrually similar to mammalian blood coagulation factor Xa. Thromb Haemost. 2004;92:509-521. (Pubitemid 39248008)
10. St. Pierre L, Masci PP, Filippovich I, et al. Comparative analysis of prothrombin activators from the venom of Australian elapids. Mol Biol Evol. 2005;22:1853-1864. (Pubitemid 41191512)
11. Owen WG, Jackson CM. Activation of prothrombin with Oxyuranus scutellatus scutellatus (taipan snake) venom. Thromb Res. 1973;3:705-714.
12. Welton RE, Burnell JN. Full length nucleotide sequence of a factor V-like subunit of oscutarin from Oxyuranus scutellatus scutellatus (coastal Taipan). Toxicon. 2005;46:328-336.
13. Jiang Y, Doolittle RF. The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes. Proc Natl Acad Sci U S A. 2003;100:7527-7532. (Pubitemid 36760003)
14. Davidson CJ, Hirt RP, Lal K, et al. Molecular evolution of the vertebrate blood coagulation network. Thromb Haemost. 2003;89:420-428. (Pubitemid 36329230)
15. Mann KG, Kalafatis M. Factor V: a combination of Dr. Jekyll and Mr. Hyde. Blood. 2002;101:20-30.
16. Toso R, Camire RM. Removal of B-domain sequences from factor V rather than specific proteolysis underlies the mechanism by which cofactor function is realized. J Biol Chem. 2004;279:21643-21650. (Pubitemid 38656576)
17. Zhu H, Toso R, Camire RM. Inhibitory sequences within the B-domain stabilize circulating factor V in an inactive state. J Biol Chem. 2007;282:15033-15039. (Pubitemid 47093344)
18. Higgins DL, Mann KG. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J Biol Chem. 1983;258:6503-6508.
19. Buddai SK, Toulokhonova L, Bergum PW, Vlasuk GP, Krishnaswamy S. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase. J Biol Chem. 2002;277:26689-26698.
20. Mann KG. Prothrombin. Methods Enzymol. 1976;45:123-156.
21. Camire RM. Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site. J Biol Chem. 2002;277:37863-37870.
22. Toso R, Camire RM. Role of hirudin-like factor Va heavy chain sequences in prothrombinase function. J Biol Chem. 2006;281:8773-8779. (Pubitemid 43847983)
23. Toso R, Zhu H, Camire RM. The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly. J Biol Chem. 2008;283:18627-18635.
24. Stafford WF. Boundary analysis in sedimentation transport experiments: a procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile. Anal Biochem. 1992;203:295-301.
25. Pryzdial ELG, Mann KG. The association of coagulation factor Xa and factor Va. J Biol Chem. 1991;266:8969-8977.
26. Boskovic DS, Giles AR, Nesheim MD. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1 2-prethrombin-2, and dansyl-1-glutamyl-glycyl-l-arginine-meizothrombin in the absence of phospholipid. J Biol Chem. 1990;265:10497-10505. (Pubitemid 20212782)
27. Esmon CT. The protein C pathway. Chest. 2003;124:26S-32S.
28. Masci PP, Rowe EA, Whitaker AN, de Jersey J. Fibrinolysis as a feature of disseminated intravascular coagulation (DIC) after Pseudonaja textilis textilis envenomation. Thromb Res. 1990;59:859-870.
29. Ortel TL, Kane WH, Keller FG. Factor V. In: High KA, Roberts HR, eds. Molecular Basis of Thrombosis and Hemostasis. New York, NY: Marcel Dekker; 1995:119-146.
30. Kane WH, Devore-Carter D, Ortel TL. Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting region. Biochemistry. 1990;29:6762-6768. (Pubitemid 20225474)
31. Keller FG, Ortel TL, Quinn-Allen MA, Kane WH. Thrombin-catalyzed activation of recombinant human factor V. Biochemistry. 1995;34:4118-4124.
32. Majumder R, Weinreb G, Zhai X, Lentz BR. Soluble phosphatidylserine triggers assembly in solution of a prothrombin-activating complex in the absence of a membrane surface. J Biol Chem. 2002;277:29765-29773.
33. Majumder R, Weinreb G, Lentz BR. Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface. Biochemistry. 2005;44:16998-17006. (Pubitemid 43007228)
34. Majumder R, Quinn-Allen MA, Kane WH, Lentz BR. A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex. Blood. 2008;112:2795-2802.
35. Mann KG, Hockin MF, Begin KJ, Kalafatis M. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain. J Biol Chem. 1997;272:20678-20683. (Pubitemid 27355631)
36. Gale AJ, Xu X, Pellequer JL, Getzoff ED, Griffin JH. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C. Protein Sci. 2002;11:2091-2101. (Pubitemid 34919613)